Anasys Instruments Corp. — Department of Health and Human Services STTR Phase II: 300

Anasys Instruments Corp. — STTR Phase II award from Department of Health and Human Services.

Amount
$976,728
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
STTR · Phase II
Topic
300
Solicitation
PA13-235
NAICS
Place of performance
CA
Period
2014-12-01 → 2017-11-30

Description

DESCRIPTION provided by applicant Anasys Instruments and Prof Lynne Taylor of Purdue propose to develop nanoscale chemical characterization capabilities for drug formulation research This project will build on successful Phase I research demonstrating feasibility of atomic force microscope based infrared spectroscopy AFM IR in pharmaceutical applications This Phase II research will advance techniques for efficiently determining morphological and chemical properties of nanostructured drug formulations leading to improvements in drug solubility This project will overcome key limitations of existing characterization tools includin the limitations of current AFM IR technology The proposed research will provide a critical new characterization tool for pharmaceutical research will enable a large commercial and research market and is expected to have significant downstream impacts on improving drug solubility and efficacy PUBLIC HEALTH RELEVANCE Anasys Instruments and Prof Lynne Taylor of Purdue propose to develop nanoscale chemical characterization capabilities for drug formulation research This project will build on successful Phase I research demonstrating feasibility of atomic force microscope based infrared spectroscopy AFM IR in pharmaceutical applications This Phase II research will advance techniques for efficiently determining morphological and chemical properties of nanostructured drug formulations leading to improvements in drug solubility